Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor

Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor

The multiplicity and phenotype of intratumoral immune infiltrate have been shown to influence the clinical outcome of hepatocellular carcinoma (HCC), thus providing a strong rationale to therapeutic interventions aimed at restoring the dysfunctional immune response against the tumor. Improving the k...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatoma research 2018-06, Vol.4 (6), p.22-65
Hauptverfasser: Missale, Gabriele, Cariani, Elisabetta
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 65
container_issue 6
container_start_page 22
container_title Hepatoma research
container_volume 4
creator Missale, Gabriele
Cariani, Elisabetta
description The multiplicity and phenotype of intratumoral immune infiltrate have been shown to influence the clinical outcome of hepatocellular carcinoma (HCC), thus providing a strong rationale to therapeutic interventions aimed at restoring the dysfunctional immune response against the tumor. Improving the knowledge of the complex interactions between transformed hepatocytes, nonparenchymal resident cells, and infiltrating immune cells (characterizing the HCC microenvironment) will be instrumental to increase the success rate of existing immunotherapeutic strategies and to identify new potential targets for intervention or biomarkers to optimize the selection of candidate patients.
doi_str_mv 10.20517/2394-5079.2018.72
format Article
fullrecord <record><control><sourceid>wanfang_jour_cross</sourceid><recordid>TN_cdi_wanfang_journals_gayj_e201806005</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><wanfj_id>gayj_e201806005</wanfj_id><sourcerecordid>gayj_e201806005</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1685-333fede7cfad18157cd4adf6a609f511078badd5e585e9e2de2f0cf3f8f9c6b23</originalsourceid><addsrcrecordid>eNo1kEtPwzAQhC0EElXpH-DkG6cUP-I8uKGKl1SJSzlbW8dOXDl2ZCeC_nvSFk47q53ZkT6E7ilZMyJo-ch4nWeClPW802pdsiu0YLnIMyYYuZ71__0WrVI6EEJYXVBe0gX62dleYxMi7vQAY1DauclBxAqisj70gG3fTz6MnY4wHJ-w9cm23ZjOoTQppVMyk8PKWW8VOAzD4GYx2uDT7MZjZxNWHTinfWt9i8epD_EO3RhwSa_-5hJ9vb7sNu_Z9vPtY_O8zRQtKpFxzo1udKkMNLSiolRNDo0poCC1EZSSstpD0wgtKqFrzRrNDFGGm8rUqtgzvkQPl7_f4A34Vh7CFP3cKFs4HqQ-ESMFIWJ2sotTxZBS1EYO0fYQj5ISeQYtTyDlCaQ8xWTJ-C-ClXRj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Missale, Gabriele ; Cariani, Elisabetta</creator><creatorcontrib>Missale, Gabriele ; Cariani, Elisabetta</creatorcontrib><description>The multiplicity and phenotype of intratumoral immune infiltrate have been shown to influence the clinical outcome of hepatocellular carcinoma (HCC), thus providing a strong rationale to therapeutic interventions aimed at restoring the dysfunctional immune response against the tumor. Improving the knowledge of the complex interactions between transformed hepatocytes, nonparenchymal resident cells, and infiltrating immune cells (characterizing the HCC microenvironment) will be instrumental to increase the success rate of existing immunotherapeutic strategies and to identify new potential targets for intervention or biomarkers to optimize the selection of candidate patients.</description><identifier>ISSN: 2394-5079</identifier><identifier>EISSN: 2454-2520</identifier><identifier>DOI: 10.20517/2394-5079.2018.72</identifier><language>eng</language><publisher>Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma 43126, Italy%Toxicology and Advanced Diagnostics, Ospedale Civile S. Agostino-Estense, Modena 41126, Italy</publisher><ispartof>Hepatoma research, 2018-06, Vol.4 (6), p.22-65</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1685-333fede7cfad18157cd4adf6a609f511078badd5e585e9e2de2f0cf3f8f9c6b23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.wanfangdata.com.cn/images/PeriodicalImages/gayj-e/gayj-e.jpg</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Missale, Gabriele</creatorcontrib><creatorcontrib>Cariani, Elisabetta</creatorcontrib><title>Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor</title><title>Hepatoma research</title><description>The multiplicity and phenotype of intratumoral immune infiltrate have been shown to influence the clinical outcome of hepatocellular carcinoma (HCC), thus providing a strong rationale to therapeutic interventions aimed at restoring the dysfunctional immune response against the tumor. Improving the knowledge of the complex interactions between transformed hepatocytes, nonparenchymal resident cells, and infiltrating immune cells (characterizing the HCC microenvironment) will be instrumental to increase the success rate of existing immunotherapeutic strategies and to identify new potential targets for intervention or biomarkers to optimize the selection of candidate patients.</description><issn>2394-5079</issn><issn>2454-2520</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNo1kEtPwzAQhC0EElXpH-DkG6cUP-I8uKGKl1SJSzlbW8dOXDl2ZCeC_nvSFk47q53ZkT6E7ilZMyJo-ch4nWeClPW802pdsiu0YLnIMyYYuZ71__0WrVI6EEJYXVBe0gX62dleYxMi7vQAY1DauclBxAqisj70gG3fTz6MnY4wHJ-w9cm23ZjOoTQppVMyk8PKWW8VOAzD4GYx2uDT7MZjZxNWHTinfWt9i8epD_EO3RhwSa_-5hJ9vb7sNu_Z9vPtY_O8zRQtKpFxzo1udKkMNLSiolRNDo0poCC1EZSSstpD0wgtKqFrzRrNDFGGm8rUqtgzvkQPl7_f4A34Vh7CFP3cKFs4HqQ-ESMFIWJ2sotTxZBS1EYO0fYQj5ISeQYtTyDlCaQ8xWTJ-C-ClXRj</recordid><startdate>20180625</startdate><enddate>20180625</enddate><creator>Missale, Gabriele</creator><creator>Cariani, Elisabetta</creator><general>Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma 43126, Italy%Toxicology and Advanced Diagnostics, Ospedale Civile S. Agostino-Estense, Modena 41126, Italy</general><scope>AAYXX</scope><scope>CITATION</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>20180625</creationdate><title>Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor</title><author>Missale, Gabriele ; Cariani, Elisabetta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1685-333fede7cfad18157cd4adf6a609f511078badd5e585e9e2de2f0cf3f8f9c6b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Missale, Gabriele</creatorcontrib><creatorcontrib>Cariani, Elisabetta</creatorcontrib><collection>CrossRef</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Hepatoma research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Missale, Gabriele</au><au>Cariani, Elisabetta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor</atitle><jtitle>Hepatoma research</jtitle><date>2018-06-25</date><risdate>2018</risdate><volume>4</volume><issue>6</issue><spage>22</spage><epage>65</epage><pages>22-65</pages><issn>2394-5079</issn><eissn>2454-2520</eissn><abstract>The multiplicity and phenotype of intratumoral immune infiltrate have been shown to influence the clinical outcome of hepatocellular carcinoma (HCC), thus providing a strong rationale to therapeutic interventions aimed at restoring the dysfunctional immune response against the tumor. Improving the knowledge of the complex interactions between transformed hepatocytes, nonparenchymal resident cells, and infiltrating immune cells (characterizing the HCC microenvironment) will be instrumental to increase the success rate of existing immunotherapeutic strategies and to identify new potential targets for intervention or biomarkers to optimize the selection of candidate patients.</abstract><pub>Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma 43126, Italy%Toxicology and Advanced Diagnostics, Ospedale Civile S. Agostino-Estense, Modena 41126, Italy</pub><doi>10.20517/2394-5079.2018.72</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2394-5079
ispartof Hepatoma research, 2018-06, Vol.4 (6), p.22-65
issn 2394-5079
2454-2520
language eng
recordid cdi_wanfang_journals_gayj_e201806005
source EZB-FREE-00999 freely available EZB journals
title Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A23%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Time%20for%20hepatocellular%20carcinoma%20immunotherapy:%20insights%20for%20successful%20clinical%20applications%20in%20this%20challenging%20tumor&rft.jtitle=Hepatoma%20research&rft.au=Missale,%20Gabriele&rft.date=2018-06-25&rft.volume=4&rft.issue=6&rft.spage=22&rft.epage=65&rft.pages=22-65&rft.issn=2394-5079&rft.eissn=2454-2520&rft_id=info:doi/10.20517/2394-5079.2018.72&rft_dat=%3Cwanfang_jour_cross%3Egayj_e201806005%3C/wanfang_jour_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_wanfj_id=gayj_e201806005&rfr_iscdi=true